JK Agri Genetics Ltd
Incorporated in 1989, JK Agri Genetics Ltd
is in the business of Agri & Allied product[1]
- Market Cap ₹ 159 Cr.
- Current Price ₹ 342
- High / Low ₹ 577 / 282
- Stock P/E
- Book Value ₹ 216
- Dividend Yield 0.00 %
- ROCE 5.35 %
- ROE -13.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.6.17 Cr.
- Company's cost of borrowing seems high
- Working capital days have increased from -11.4 days to 116 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 162 | 158 | |
| 172 | 155 | |
| Operating Profit | -10 | 2 |
| OPM % | -6% | 2% |
| 18 | 6 | |
| Interest | 6 | 5 |
| Depreciation | 4 | 4 |
| Profit before tax | -2 | 0 |
| Tax % | 2% | 2,858% |
| -3 | -7 | |
| EPS in Rs | -5.41 | -15.46 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -15% |
| 3 Years: | -8% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 5 | 5 |
| Reserves | 103 | 96 |
| 3 | 0 | |
| 187 | 172 | |
| Total Liabilities | 297 | 272 |
| 19 | 29 | |
| CWIP | 18 | 0 |
| Investments | 98 | 73 |
| 162 | 170 | |
| Total Assets | 297 | 272 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 3 | -28 | |
| 32 | 30 | |
| -34 | -7 | |
| Net Cash Flow | 1 | -5 |
| Free Cash Flow | 72 | -29 |
| CFO/OP | -42% | -1,117% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 96 | 88 |
| Inventory Days | 301 | 390 |
| Days Payable | 387 | 330 |
| Cash Conversion Cycle | 9 | 149 |
| Working Capital Days | -139 | 116 |
| ROCE % | 5% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of R&D Facilities Count ・Standalone data |
|
||||||||||
| R&D Expenditure INR Lacs ・Standalone data |
|||||||||||
| Number of permanent employees Count ・Standalone data |
|||||||||||
| Export revenue contribution INR Lacs ・Standalone data |
|||||||||||
| Number of distributors Count ・Standalone data |
|||||||||||
| Number of Multi-location Trial Centers Count ・Standalone data |
|||||||||||
| Export revenue contribution Percentage ・Standalone data |
|||||||||||
| Number of new hybrids launched Count ・Standalone data |
|||||||||||
| Number of retailers Count ・Standalone data |
|||||||||||
| Number of scientists Count ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 May - Newspaper Publication in respect of Special Window for Transfer and Dematerialisation of Physical Securities and Second 100 Days Campaign - "Saksham Niveshak" - for KYC …
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
12 May - Filed Annual Secretarial Compliance Report for FY ended 31 March 2026, dated 6 May 2026.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
8 May - Board approved reappointment of Kuldeep Kumar Pandit as President & Director for three years from 24 Nov 2026.
-
Audited Financial Results For The Financial Year Ended 31St March 2026
8 May - Board approved audited Q4 and FY2026 results on 8 May 2026; no dividend recommended.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th May 2026
8 May - Audited Q4/FY26 results approved on 8 May 2026; no dividend recommended, unmodified audit opinion.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
JKAGL is a part of JK Group. It is in the research and development, production, processing, and marketing of Field Crops, Cotton, Vegetables, Plant Nutrition, etc. Company sells products under the brand name JK Seeds